Summary: The Centers for Medicare & Medicaid Services modified its leadless pacemaker coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.
CMS leadless pacemaker coverage policy has been updated, and if your practice or facility bills for cardiac device implantation, this change deserves your full attention now. The Centers for Medicare & Medicaid Services has modified its policy governing leadless cardiac pacing devices — a category that has seen rapid clinical adoption over the past several years and, not coincidentally, growing scrutiny from payers. This policy does not list specific codes in the available data, but leadless pacemaker billing typically involves a cluster of CPT and HCPCS codes your charge capture team should already have flagged. We'll walk through what the modification means, what to watch for, and what to do before May 15, 2026.
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Leadless Pacemakers |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Cardiology, Electrophysiology, Cardiac Surgery, Hospital Outpatient Departments |
| Key Action | Audit your leadless pacemaker claims and documentation before May 15, 2026 to confirm they meet updated medical necessity criteria |
CMS Leadless Pacemaker Coverage Criteria and Medical Necessity Requirements 2026
Leadless pacemakers represent a meaningful shift in cardiac pacing technology. Traditional transvenous pacemakers require leads — thin wires threaded through veins into the heart. Leadless devices implant directly into the right ventricle (and now, with newer dual-chamber systems, across both chambers). CMS has been watching this space carefully.
The core issue with any CMS coverage policy modification in this category is medical necessity. CMS ties reimbursement for leadless pacemakers to documented clinical justification. That means your physicians' notes need to clearly establish why the patient is not a candidate for — or would benefit more from — a leadless device over conventional transvenous pacing.
Because the specific criteria document for this modification was not available in the policy data at time of publication, the exact updated language is not reproduced here. What is known: CMS modified this policy effective May 15, 2026, which signals a coverage or criteria change — not a minor administrative update. Modifications of this type typically affect one or more of the following: patient eligibility criteria, documentation requirements, prior authorization requirements, or covered indications. Your team needs to pull the full policy text from the CMS source before the effective date.
Review the full policy at the CMS source linked in the quick-reference table above. If you work with a Medicare Administrative Contractor, contact your MAC directly for implementation guidance specific to your region.
Medical necessity documentation failures are the leading cause of claim denial for high-cost cardiac device implants. That is not going to change with this modification — if anything, a policy update raises the documentation bar.
CMS Leadless Pacemaker Coverage Criteria: What Has Historically Applied
Even without the full modified policy text, we can give you a clear picture of how CMS has approached leadless pacemaker coverage — and what the updated policy will likely build on.
CMS has historically covered single-chamber leadless pacemakers (right ventricular pacing) for patients with specific indications. These include patients with atrial fibrillation with high-degree AV block, patients who lack venous access for transvenous leads, and patients with prior device infections making them high-risk for traditional implants. Coverage has generally required documentation of the underlying rhythm disorder and clear clinical rationale for the leadless approach.
The 2024 FDA approval of dual-chamber leadless pacing systems changed the landscape for both clinicians and payers. CMS coverage policy for dual-chamber leadless devices is newer and more contested. If this modification addresses dual-chamber systems specifically, that has major financial exposure for electrophysiology programs doing volume in this space.
Prior authorization requirements for leadless pacemakers vary by Medicare Advantage plan, but under traditional Medicare (fee-for-service), prior authorization has not historically been required for these devices. That may or may not change with this modification. Confirm the updated prior auth requirements with your MAC before billing after May 15, 2026.
CMS Leadless Pacemaker Exclusions and Non-Covered Indications
Based on historical CMS coverage policy patterns for leadless pacemakers, coverage has not extended to several scenarios. These exclusions are consistent with prior CMS guidance and likely persist in the modified policy — but confirm against the actual updated policy text.
Leadless pacemakers implanted as a first-line choice without documented contraindication to conventional transvenous pacing have faced denial risk. CMS has generally expected documentation showing why a leadless approach is medically appropriate for the specific patient — not simply preferred by the physician or patient.
Dual-chamber leadless systems implanted in patients who do not meet the specific electrophysiological criteria for that technology have also faced scrutiny. As this technology is newer, CMS coverage policy for dual-chamber devices is still evolving, and this modification may directly address that.
Replacement or revision procedures for leadless devices carry their own coverage considerations. If a device requires retrieval and reimplantation, the documentation and billing pathway differs from a primary implant. Make sure your coding team distinguishes primary implants from revision procedures in charge capture.
Coverage Indications at a Glance
Because the specific modified policy text was not available in the data provided, this table reflects the known historical CMS coverage framework for leadless pacemakers. Verify each indication against the May 15, 2026 policy update before using this as a billing reference.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Single-chamber leadless pacing — AV block with chronic atrial fibrillation | Historically Covered | See codes section | Medical necessity documentation required |
| Single-chamber leadless pacing — inadequate venous access for transvenous lead | Historically Covered | See codes section | Physician must document anatomical or clinical barrier to transvenous approach |
| Single-chamber leadless pacing — prior device infection / high infection risk | Historically Covered | See codes section | Prior infection history must be in the record |
| Dual-chamber leadless pacing systems | Coverage Evolving / Confirm Against Modified Policy | See codes section | FDA approval is recent; CMS coverage may have changed in this modification |
| Leadless pacing without documented contraindication to conventional pacing | Historically Not Covered | N/A | Claim denial risk without clinical rationale for leadless approach |
| Prophylactic implant without rhythm disorder diagnosis | Not Covered | N/A | Must have documented diagnosis driving medical necessity |
CMS Leadless Pacemaker Billing Guidelines and Action Items 2026
Here is what your team should do right now, before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the full modified policy text from CMS. The policy data available at publication did not include the full criteria document. Go to the CMS source directly and get the actual updated language. Do not bill based on your current workflow until you've confirmed what changed. |
| 2 | Audit your open and pending leadless pacemaker claims. Any claim submitted or pending after May 15, 2026 falls under the modified policy. Review your charge capture queue for leadless pacemaker billing and hold anything that hasn't been confirmed against the new criteria. |
| 3 | Confirm prior authorization requirements with your MAC. If this modification introduces a prior auth requirement where none previously existed, you need to know that before implanting a device. A claim denial after a $30,000+ procedure is a bad outcome for everyone. Contact your Medicare Administrative Contractor and ask directly. |
| 4 | Review your physician documentation templates. Medical necessity documentation is your first line of defense against claim denial. Update your procedure note templates to reflect whatever the updated coverage criteria require. This is especially important for dual-chamber leadless systems if the modification addresses that technology specifically. |
| 5 | Brief your electrophysiology and cardiology physicians on the effective date. Physicians often don't track payer policy changes. Your job is to make sure they know that documentation requirements may have shifted as of May 15, 2026, and what the clinical record needs to show. |
| 6 | If your facility has high leadless pacemaker volume, talk to your compliance officer now. This is a high-dollar, high-scrutiny procedure category. A coverage policy modification from CMS in this space has real revenue exposure. Your compliance officer should be reviewing the modified policy and assessing your current documentation practices against the new criteria before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Leadless Pacemakers Under CMS Policy
The modified CMS policy data provided did not include specific CPT, HCPCS, or ICD-10 codes. The policy document does not list specific codes in the available data. Do not use fabricated codes for leadless pacemaker billing.
That said, leadless pacemaker billing involves a defined set of codes that your coding team should already be working with. Pull your current code list from your charge description master and cross-reference it against the AMA CPT codebook for cardiac pacing, the HCPCS device codes for leadless pacing systems, and any MAC-issued billing guidance specific to this technology.
When the full modified policy text is available from CMS, confirm that every code in your current charge capture is still covered under the updated criteria. If any codes have been removed, restricted, or reclassified, update your charge master before May 15, 2026.
For the most current and complete code list, access the full policy at the CMS source. PayerPolicy users can also search across the platform by specialty or procedure to surface any related LCD or NCD changes from Medicare Administrative Contractors that intersect with this national-level update.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.